Botox (OnabotulinumtoxinA) Botox 2023 Sales: $5.673 billion Company/Developer: AbbVie Date of First FDA Approval: December 29, 1989 Indications Botox Is FDA-Approved for: Botox is an acetylcholine release inhibitor and neuromuscular blocking agent indicated for chronic migraine, urinary incontinence and overactive bladder, cervical dystonia, neurogenic detrusor overactivity, spasticity, severe axillary hyperhidrosis, and for cosmetic purposes (Botox cosmetic) WAC of Botox: Cost depends heavily on the condition and dose required, but the list price is $1,244 for a 200-unit vial
This means the compounded drug may not be identical or nearly identical to an FDA-approved drug unless the approved drug is on the FDAs drug shortage list
When in doubt, consulting your healthcare provider is always the safest approach
With the guidance of a healthcare provider, individuals can take the first step towards achieving optimal health and wellness
Este es el primer estudio que examina los efectos de los agonistas del receptor de GLP-1 en personas con obesidad y otros tipos de enfermedades autoinmunes, incluidas las gastrointestinales (p
The glucagon-like peptide-1 receptor agonist (GLP-1 RA) is already approved for use in the treatment of obesity and for weight management
